Kazuo Saito1, Yumiko Saito2, Kyoko Hirota2, Hirotaka Matui2, Kimitaka Hase3. 1. Department of Rehabilitation, Faculty of Health Sciences, Tokyo Kasei University: 2-15-1 Inariyama, Sayama, Saitama 350-1398, Japan. 2. Department of Rehabilitation, Fuchinobe General Hospital, Japan. 3. Department of Rehabilitation Medicine, Kansai Medical University, Japan.
Using botulinum toxin type A (BoNT-A), it is possible to actively and properly control
muscle spasms and simultaneously implement rehabilitative activities, such as stretching and
exercise therapy1,2,3). Although there have been
reports on functional improvement in proximal upper limb muscles from the combined use of
BoNT-A and rehabilitation4, 5), there are few reports on functional improvement in distal
muscles, particularly those of the fingers. There are also insufficient reports on the
long-term effects of BoNT-A6). In this
study, we report our experience of a patient with spinal cord injury who underwent long-term
combined treatments using BoNT-A and rehabilitation. The patient showed improved motor
functions in the fingers and upper limb, and regained some hand movements that led to
improvements in activities of daily life (ADL).
PARTICIPANT AND METHODS
The patient was a 60 year-old man who had central spinal cord injury (C4). At an initial
evaluation 9 months after the injury, the patient was quadriplegic (C5 level, quadriparesis,
severe distal, and severe right-sided paralysis) and used an electronic wheelchair. There
were no abnormalities in his mental functions. There was moderate contracture from the wrist
joint to the fingers. Although the muscle tone was increased in the extremities and the
trunk, it was significantly increased in the upper limbs and associated with pain in the
extremities. The Modified Ashworth scale (MAS) scores were more severe in the right finger
flexors than in the left. We identified hypoesthesia on both sides below the C5 level and
skin hypersensitivity at the C7–C8 level. The patient was almost fully assisted in all ADLs.
His Motor Functional Independence Measure (M-FIM) score was 34 points. The ADL he could
perform included eating using his left hand (with self-help tools like spoons and forks) and
independent motion using an electronic wheelchair (lever operated) but required assistance
for all other activities.Outpatient rehabilitation involved physical therapy and occupational therapy twice weekly,
but because spasms and pain gradually became more profound, we started giving the patient
BoNT-A about 1 year and 3 months after the injury. We gave a total of 14 BoNT-A injections
periodically for 7 years and 4 months after the injury. We injected 2–5 proximal upper limb
muscles and 2–4 distal upper limb muscles during each treatment. The injections were given
at an average interval of 5.6 months (3 to 10 months) (Fig. 1a). About 4 years after the injury, we attempted to tape the patient’s hands, but
redness and itchiness ultimately made taping difficult; therefore, splints were used instead
of tapes. The redness and pain associated with the use of splint were tolerable, thus, the
patient wore the splints for several minutes during the day and gradually increased the
wearing time until he could wear them for 6–8 hours at night. The splints were remade and
appropriately corrected to allow easy extension of the splint as the muscle tone and
contracture of the fingers improved (Figs. 1b and
2). The study was approved by the Fuchinobe General Hospital Ethics Committee (Approval
No. 18-003). The participant provided written informed consent.
Fig. 1.
Patient’s progress over time while receiving BoNT-A, splint frequency and
rehabilitation.
1a. BoNT-A of upper extremity dispensing interval average 5.6 months (range
3–10M).
ROM: range of motion; MAS: Modified Ashworth Scale; FDS: flexor digitorum
superficialis; PIP: proximal interphalangeal joint.
Patient’s progress over time while receiving BoNT-A, splint frequency and
rehabilitation.1a. BoNT-A of upper extremity dispensing interval average 5.6 months (range
3–10M).1b. Splint progress 4 months after injury.BoNT-A: botulinum toxin type A; FPL: flexor pollicis longus; FDS: flexor digitorum
superficialis; ADD: adductor pollicis; Subs: subscapularis; PT: pronator teres; LaD:
Latissimus dorsi; Del: deltoid; PM: pectoralis major; Lum: lumbricals; TMi: teres
minor; TMa: teres major.Progression in the usage of the splint types.ROM: range of motion; MAS: Modified Ashworth Scale; FDS: flexor digitorum
superficialis; PIP: proximal interphalangeal joint.
RESULTS
After 7 years of sustaining spinal cord injury, passive range of motion (ROM) (right/left)
showed significant improvement 4 months after commencing BoNT-A therapy (145/180 for
shoulder flexion, 140/145 for elbow flexion, and −20/0 for extension). The joints of the
fingers showed clear improvements after about 4 months (Fig. 3a) and there was improvement in automatic exercise and improvements in passive ROM2). The MAS scores similarly indicated the
alleviation of spasm in the proximal upper limb muscles after about 4 months. There were
improvements in the distal upper limb muscles, and the improved scores were 1/0 for elbow
flexors, 2/1+ for wrist flexors, and 1–3/1–3 for finger flexors (Fig. 2 and Fig. 3b).
Sensory disorders in the C7 region improved, and skin hypersensitivity gradually reduced
about 3 months after the injury. Aside from using his left hand to eat and operate an
electronic wheelchair, the patient continued to require full assistance in ADL, and his
M-FIM score was 42 points. Owing to the increase in the ROM of the patient’s upper limb, he
required less assistance with wearing clothes, donning and doffing clothes, and for sanitary
purposes (Fig. 4). The patient was capable of cooperative movements when assistance was provided, such
as extending the standing time by holding onto the handrail with the left elbow to remain
standing. The patient’s left hand, which was always capable of eating movements, increased
in its range of use after the intervention, as the speed of eating became faster. In
addition, he could also operate his smartphone and the elevators, smoke cigarettes, and
write letters and numbers with his left hand (Fig.
4). We noticed the patient’s proactive mindset with changes in behavior, such as
finding wearable assistive instruments for his right side by himself and actively advising
that the splint was not fitting as improvements progressed in the fingers.
Fig. 3.
Graph of ROM and MAS scores over time showing improvements in motor function and
usage of the hands.
3a. Passive ROM of the index finger’s PIP joint.
3b. Modified Ashworth Scale (MAS) FDS of Index.
FDS: flexor digitorum superficialis; MAS: Modified Ashworth Scale; PIP: proximal
interphalangeal joint; ROM: range of motion.
Fig. 4.
Improvement in motor function and usage of the hands.
Graph of ROM and MAS scores over time showing improvements in motor function and
usage of the hands.3a. Passive ROM of the index finger’s PIP joint.3b. Modified Ashworth Scale (MAS) FDS of Index.FDS: flexor digitorum superficialis; MAS: Modified Ashworth Scale; PIP: proximal
interphalangeal joint; ROM: range of motion.Improvement in motor function and usage of the hands.
DISCUSSION
It has been reported that even though the effect of BoNT-A wears off after 3–4 months,
combining BoNT-A treatment with rehabilitation could have a carry-over effect3,4,5). This patient began to experience gradual
alleviation of spasms in the proximal muscles of the upper limb and improvement in ROM,
2 years following the injury, after receiving 4–5 BoNT-A injections, and these trends
supported the carry-over effect theory. In addition, the spasms and ROM in the fingers
gradually improved about 4 years after the injury through the combination of splint therapy,
administration of BoNT-A, and rehabilitation. Previous reports have indicated that the
combination of BoNT-A and splint therapy can lead to positive improvements in finger
spasticity and ROM7, 8). There are also several reports indicating that taping is more
effective than splints9, 10). We think this is because taping complements the fingers’
state as they change in form and functionality. As this patient presented with skin
hypersensitivity about 2 years after the injury, the use of taping was considered difficult;
therefore, splint therapy was used when skin hypersensitivity alleviated. Extension using
splints prevented the deterioration of skin hypersensitivity and led to improvements in ROM.
We believe that gradually modifying the shape of the splint to allow proper extension
according to the changes in the patient, makes this measure effective9, 10). We suggest that
sustained extension (after correcting the splint in accordance with the improvement in the
distal muscles and finger joint contracture) is effective in cases such as this patient. In
the future, we would like to determine what level of extension of the splint would be
effective in cases with finger spasms.
Conflict of interest
The authors have no conflicts of interest to disclose regarding this work.
Authors: D M Simpson; J-M Gracies; H K Graham; J M Miyasaki; M Naumann; B Russman; L L Simpson; Y So Journal: Neurology Date: 2008-05-06 Impact factor: 9.910
Authors: Jonathan Levy; Franco Molteni; Giovanni Cannaviello; Thibaud Lansaman; Nicolas Roche; Djamel Bensmail Journal: Ann Phys Rehabil Med Date: 2018-06-28
Authors: A D Kanellopoulos; A F Mavrogenis; E A Mitsiokapa; D Panagopoulos; H Skouteli; S G Vrettos; G Tzanos; P J Papagelopoulos Journal: Eur J Phys Rehabil Med Date: 2009-01-21 Impact factor: 2.874
Authors: Natasha A Lannin; Louise Ada; Coralie English; Julie Ratcliffe; Steven G Faux; Mithu Palit; Senen Gonzalez; John Olver; Ian Cameron; Maria Crotty Journal: Stroke Date: 2019-12-09 Impact factor: 7.914